首页> 外文OA文献 >A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

【2h】

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

机译：培美曲塞联合顺铂联合一线治疗晚期，非鳞状，非小细胞肺癌一线治疗后比较培美曲塞加最佳支持治疗与最佳支持治疗作为维持治疗的随机2期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mubarak Nabil; Gaafar Rabab; Shehata Samir; Hashem Tarek; Abigeres Dani; Azim Hamdy A; El-Husseiny Gamal; Al-Husaini Hamed; Liu Zhixin;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): A double-blind, phase 3, randomised controlled trial [J] . Paz-AresL., deMarinisF., DediuM., The lancet oncology . 2012,第3期

机译：培美曲塞加顺铂诱导治疗晚期非鳞状非小细胞肺癌（PARAMOUNT）后，培美曲塞加最佳支持治疗与安慰剂加最佳支持治疗的维持治疗：一项双盲，3期，随机对照试验
2. Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer [J] . Luis G Paz-Ares, Sedat Altug, Alexandra Thareau Vaury, BMC Cancer . 2010,第1期

机译：培美曲塞加顺铂诱导治疗晚期非鳞状非小细胞肺癌后立即进行培美曲塞加最佳支持治疗与最佳支持治疗的III期，双盲，安慰剂对照研究的治疗原理和研究设计
3. PARAMOUNT: Final Overall Survival (OS) Results of the Phase III Study of Maintenance Pemetrexed (pem) Plus Best Supportive Care (BSC) Versus Placebo (plb) Plus BSC Immediately Following Induction Treatment With Pem Plus Cisplatin (Cis) for Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla11期

机译：PARAMOUNT：培美曲塞（pem）+最佳支持治疗（BSC）与安慰剂（plb）+ BSC维持治疗的培美曲塞（pem）加BSC对晚期非鳞状（NS）诱导后立即进行的III期研究的最终总体生存（OS）结果非小细胞肺癌（NSCLC）
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. A randomized phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer [O] . Nabil Mubarak, Rabab Gaafar, Samir Shehata, 2012

机译：一项随机2期研究比较了培美曲塞加顺铂联合一线治疗晚期非鳞状非小细胞肺癌的培美曲塞加最佳支持治疗与最佳支持治疗作为维持治疗
7. A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer [O] . Nabil Mubarak, Rabab Gaafar, Samir Shehata, 2012

机译：一项随机，2期研究比较了培美曲塞加顺铂联合一线治疗晚期，非鳞状，非小细胞肺癌的培美曲塞加最佳支持治疗与最佳支持治疗作为维持治疗

A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

著录项

相似文献

相关主题

期刊订阅